Medical News Today
January 11, 2024
A team of researchers has developed a molecular assay test that detects alpha-synuclein fibrils in brain tissue and cerebrospinal fluid samples from people with Parkinson’s disease. The researchers hope this technique may lead to clinical tests that can diagnose PD in its early stages and might even lead to more effective treatments. Michael S. Okun, MD, national medical advisor for the Parkinson’s Foundation, provides commentary.